Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT05316233
PHASE3

JUVÉDERM® VOLITE™ XC Injectable Gel for Improvement in Neck Appearance

Sponsor: AbbVie

View on ClinicalTrials.gov

Summary

The cumulative effects of aging, weight change, ergonomics (i.e., "tech neck"), and environmental exposures (i.e., ultraviolet, infrared, and visible light radiation and pollution) leads to wrinkles, discoloration, laxity, and roughness of sun exposed skin. The neck is a frequently mentioned area by patients complaining about its crepey texture and deep lines. VOLITE XC is a crosslinked hyaluronic acid (HA) gel implant formulated with lidocaine that was developed to provide a safe, minimally invasive method of treating fine lines and improving skin smoothness. The purpose of this study is to assess safety and effectiveness of VOLITE XC in adults seeking improvement in neck appearance. VOLITE XC is an investigational product intended to reduce horizontal neck lines for improvement of neck appearance. Participants are placed in 1 of 2 groups, called treatment arms. Participation will be randomized in a 2:1 ratio in treatment and control arms. Up to 212 adult participants with moderate or severe transverse neck lines will be enrolled in the study at up to 20 sites. Participants in the treatment group will receive VOLITE XC at Day 1 and be followed for up to 14 Months. Participants will have the opportunity to receive optional touch-up and optional repeat treatment of VOLITE XC during the follow-up duration period. The control group received no treatment and will be followed for up to 6 months after randomization. Participants can then opt to receive VOLITE XC and be followed for 6 Months. There may be higher treatment burden for participants in this trial compared to their standard of care. Participants will attend regular visits during the study at a hospital or clinic. The effect of the treatment will be checked by medical assessments, checking for side effects, and completing questionnaires.

Official title: Multicenter, Evaluator-blinded, Randomized, Controlled Study of the Safety and Effectiveness of JUVÉDERM® VOLITE™ XC Injectable Gel for Improvement in Neck Appearance

Key Details

Gender

All

Age Range

22 Years - Any

Study Type

INTERVENTIONAL

Enrollment

159

Start Date

2022-05-02

Completion Date

2024-09-12

Last Updated

2026-09-03

Healthy Volunteers

No

Conditions

Interventions

DEVICE

VOLITE XC

Intradermal Injection

DEVICE

VOLITE XC

Subdermal Injection

Locations (15)

Steve Yoelin MD Medical Associate Inc /ID# 239072

Newport Beach, California, United States

Laser & Skin surgery Medical group, Inc /ID# 241999

Sacramento, California, United States

Cosmetic Laser Dermatology /ID# 239121

San Diego, California, United States

Art of Skin MD /ID# 239071

Solana Beach, California, United States

Center for Dermatology and Dermatologic Surgery /ID# 239137

Washington D.C., District of Columbia, United States

Hevia Cosmetic Dermatology /ID# 239118

Coral Gables, Florida, United States

Skin Research Institute LLC /ID# 239109

Coral Gables, Florida, United States

Research Institute of the Southeast, LLC /ID# 239070

West Palm Beach, Florida, United States

Delricht Research /ID# 242001

New Orleans, Louisiana, United States

Rkmd, Llc /Id# 239075

North Bethesda, Maryland, United States

image Dermatology, P.C. /ID# 239136

Montclair, New Jersey, United States

Skin And Aesthetics Surgery Of Manhattan /ID# 243607

New York, New York, United States

Mariwalla Dermatology /ID# 239102

West Islip, New York, United States

Aesthetic Solutions /ID# 239074

Chapel Hill, North Carolina, United States

Bellaire Dermatology Associates /ID# 239133

Bellaire, Texas, United States